| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3393 | |||||||||||||||||||||||
| Submitter : | Mr. Michael Glynn | Date & Time: | 12/18/2006 09:12:19 | |||||||||||||||||||||
| Organization : | Knights of Columbus | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| FDA should make it clear that no person's life, regardless of age and state of development, will be forfeited for the sake of others. | ||||||||||||||||||||||||